Advertisement

Heart and Vessels

, Volume 1, Issue 2, pp 74–77 | Cite as

Nicardipine releases sustained coronary arterial constriction induced by acetylcholine in the rhesus monkey

  • Keisuke Satoh
  • Mitsuo Kawada
  • Yukio Wada
  • Norio Taira
Originals

Summary

In five rhesus monkeys (Macaca mulatta) the vascular bed of the left anterior descending coronary artery (LAD) was perfused at constant pressure with autologous blood. Nicardipine (1–30µm), a dihydropyridine calcium antagonist when injected into the LAD, increased LAD flow without producing significant changes in other cardiohemodynamic variables. With continuous infusions of acetylcholine into the LAD, the flow decreased by about 34% of the basal value. Under these conditions, intra-LAD nicardipine produced an increase in LAD flow almost to the same extent as in the control. The effects of nicardipine were qualitatively similar to those of other calcium antagonists observed in previous experiments and indicate that nicardipine would be useful as an antianginal drug.

Key words

Calcium antagonist Coronary circulation Coronary spasm Rhesus moneky 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Takenaka T, Usuda S, Nomura T, Maeno H, Sado T (1978) Vasodilator profile of a new 1,4-dihydropyridine derivative, 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-[2-(N-benzyl-N-methylamino)]-ethyl ester 5-methyl ester hydrochloride (YC-93). Arzneim Forsch 26: 2172–2178Google Scholar
  2. 2.
    Satoh K, Yanagisawa T, Taira N (1980) Mechanisms underlying the cardiovascular action of a new dihydropyridine vasodilator, YC-93. Clin Exp Pharmacol Physiol 7: 249–262PubMedGoogle Scholar
  3. 3.
    Nakaya H, Kanno M (1982) Effects of nicardipine, a new dihydropyridine vasodilator, on coronary circulation and ischemia-induced conduction delay in dogs. Arzneim Forsch 32: 626–629Google Scholar
  4. 4.
    Hof RP (1983) Calcium antagonist and the peripheral circulation: Differences and similarities between PY 108–068, nicardipine, verapamil and diltiazem. Br J Pharmacol 78: 375–394PubMedGoogle Scholar
  5. 5.
    Taira N (1979) Effects of diltiazem and other calciumantagonists on cardiac functions and coronary blood flow as assessed in blood-perfused dog-heart preparations. In: Bing RJ (ed) New drug therapy with a calcium antagonist. Diltiazem Hakone Symposium 1978. Excerpta Medica, Amsterdam Princeton, pp 91–103Google Scholar
  6. 6.
    Hosoda S, Kimura E (1976) Efficacy of nifedipine in the variant form of angina pectoris. In: Jatene AD, Lichtlen PR (eds) 3rd International Adalat Symposium. New therapy of ischemic heart disease. Excerpta Medica, Amsterdam Oxford, pp 195–199Google Scholar
  7. 7.
    Yasue H, Omote S, Takizawa A, Nagao M, Miwa K, Tanaka S (1979) Exertional angina pectoris caused by coronary arterial spasm: Effects of various drugs. Am J Cardiol 43: 647–652PubMedGoogle Scholar
  8. 8.
    Taira N, Satoh K, Maruyama M, Yamashita S (1983) Sustained coronary constriction and its antagonism by calcium-blocking agents in monkeys and baboons. Circ Res 52(Suppl I): 40–46Google Scholar
  9. 9.
    Sakamoto N, Terai M, Takenaka T, Maeno H (1978) Inhibition of cyclic AMP phosphodiesterase by 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-[2-(N-benzyl-N-methylamino)]ethyl ester 5-methyl ester hydrochloride (YC-93), a potent vasodilator. Biochem Pharmacol 27: 1269–1274PubMedGoogle Scholar
  10. 10.
    Terai M, Takenaka T, Maeno H (1980) Inhibition of calcium influx in rabbit aorta by nicardipine hydrochloride (YC-93). Biochem Pharmacol 30: 375–378Google Scholar
  11. 11.
    Fleckenstein A (1981) Fundamental actions of calcium antagonists on myocardial and cardiac pacemaker cell membranes. In: Weiss GB (ed) New perspectives on calcium antagonists. American Physiological Society, Bethesda, pp 59–81Google Scholar
  12. 12.
    Satoh K, Yamashita S, Maruyama M, Taira N (1982) Comparison of the responses of the simian and canine coronary circulations to autonomic drugs. J Cardiovasc Pharmacol 4: 820–828PubMedGoogle Scholar
  13. 13.
    Satoh K, Maruyama M, Yamashita S, Taira N (1984) Nicorandil releases acetylcholine-induced sustained coronary arterial constriction in monkeys and baboons. Jpn Heart J 25: 267–273PubMedGoogle Scholar
  14. 14.
    Grün-Fleckenstein G, Fleckenstein A (1980) Calcium-Antagonismus, ein Grundprinzip der Vasodilatation. In: Fleckenstein A, Roskamm H (eds) Calcium-Antagonismus. Springer, Berlin Heidelberg New York, pp 191–207Google Scholar

Copyright information

© Springer-Verlag 1985

Authors and Affiliations

  • Keisuke Satoh
    • 1
  • Mitsuo Kawada
    • 1
  • Yukio Wada
    • 1
  • Norio Taira
    • 1
  1. 1.Department of PharmacologyTohoku University School of MedicineSendaiJapan

Personalised recommendations